Yang Yuwei, Liu Liting, Yuan Lixia, Liu Xiaoya, Ding Haoying, Zhou Xu, Cao Qianan
Graduate School, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, 330004, People's Republic of China.
The First Department of Acupuncture and Moxibustion, The Affiliated Hospital of Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, 330004, People's Republic of China.
J Pain Res. 2025 May 5;18:2307-2319. doi: 10.2147/JPR.S512711. eCollection 2025.
Electroacupuncture, validated in preclinical studies, is a promising alternative approach for lumbar disc herniation with radiculopathy (LDHR). This trial aims to evaluate the efficacy and safety of electroacupuncture in patients with LDHR.
This randomized, single-blind, sham-controlled trial will enroll 170 participants diagnosed with LDHR and who present Numerical Rating Scale (NRS) scores ≥4 for both lower back and leg pain. Participants will be allocated at a 1:1 ratio to receive either electroacupuncture or sham electroacupuncture (superficial needling at nonacupoint sites). The sample size was determined based on pilot study data and power calculations. Treatments will be administered three times weekly over 8 weeks (24 sessions total), with blinding maintained throughout. An 18-week noninterventional follow-up will be extended to address the knowledge gap regarding the durability of neuromodulatory effects of electroacupuncture. The following outcomes will be evaluated: 1) primary outcome: the proportion of responders achieving ≥ a 2-point NRS reduction in both lower back and leg pain from baseline at weeks 8 and 24; 2) secondary outcomes: changes from baseline at weeks 4, 8, 16, and 24 in the intensity of low back pain and leg pain, level of disability, severity of depression and anxiety, sleep quality, as well as the incidence of lumbar spine surgery and the proportion of use of analgesics at weeks 8 and 24; and 3) safety outcome: the incidence of adverse events. The efficacy outcomes will be analyzed based on the full analysis set with the modified intention-to-treat principle. Treatment effects will be estimated using a generalized linear mixed-effects model for repeated measures. Blinding validity will be assessed via James's and Bang's indices.
This rigorously designed randomized controlled trial will generate confirmatory evidence to support the efficacy and safety of electroacupuncture in the treatment of LDHR.
NCT06611332 (https://clinicaltrials.gov/study/NCT06611332).
电针疗法已在临床前研究中得到验证,是一种治疗腰椎间盘突出症伴神经根病(LDHR)的有前景的替代方法。本试验旨在评估电针疗法对LDHR患者的疗效和安全性。
本随机、单盲、假对照试验将招募170名被诊断为LDHR且下背部和腿部疼痛的数字评分量表(NRS)评分均≥4的参与者。参与者将按1:1的比例分配,接受电针治疗或假电针治疗(在非穴位部位浅刺)。样本量根据预试验数据和效能计算确定。治疗将每周进行3次,持续8周(共24次治疗),全程保持盲法。将进行18周的非干预性随访,以填补关于电针神经调节作用持久性的知识空白。将评估以下结果:1)主要结果:在第8周和第24周时,与基线相比,下背部和腿部疼痛的NRS评分均降低≥2分的应答者比例;2)次要结果:在第4、8、16和24周时,下背部疼痛和腿部疼痛强度、残疾程度、抑郁和焦虑严重程度、睡眠质量的基线变化,以及在第8周和第24周时腰椎手术的发生率和镇痛药的使用比例;3)安全性结果:不良事件的发生率。疗效结果将根据采用改良意向性分析原则的全分析集进行分析。治疗效果将使用重复测量的广义线性混合效应模型进行估计。将通过詹姆斯指数和邦指数评估盲法的有效性。
这项设计严谨的随机对照试验将产生确证性证据,以支持电针疗法治疗LDHR的疗效和安全性。
NCT06611332(https://clinicaltrials.gov/study/NCT06611332)。